Companies with a Future performance score of at least 3, ordered by Future performance score.
MagForce AG operates in the field of nanotechnology-based cancer treatment in Germany and Poland.
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide.
VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe.
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe.
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany.
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany.
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany.
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide.
MEDICLIN Aktiengesellschaft operates hospitals in Germany.
